Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Nitric Oxide in Fontan Physiology
NCT01607983Phase 3Withdrawn
- Sponsor
- University of California, San Francisco
- Start
- Jun 2012
- Primary completion
- Dec 2017
- Modality
- DNA Intercalators/Alkylators, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 3 trial of nitric oxide, sponsored by University of California, San Francisco. Planned start Jun 2012; status: withdrawn.
02
Drugs
nitric oxide
Beyond the preview
Go deeper on NCT01607983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01607983.